FDA issued a Warning Letter to Zhejiang Hisoar Pharmaceutical Co. Ltd. on 8/11/2016 as a result of this inspection.
483 Zhejiang Hisoar Pharmaceutical Aug 2015

483 Zhejiang Hisoar Pharmaceutical Aug 2015

Peter Baker FDA$119.00 - Available Now

FDA investigators audited the Zhejiang Hisoar Pharmaceutical - Taizhou City, China facility and issued 7 inspectional observations (via FDA 483) on 13 Aug 2015.

Product details

  • Category: Animal Drugs & Feeds / Human Drugs
  • Number of Observations: 7
  • Inspection end: 13 Aug 2015
  • Location: Taizhou City, China
  • FEI: 3003735151
Add To Cart